Pediatr Nephrol 2017; 32:1989.
431 431. Nakka P, Smith SP, O'Donnell‐Luria AH, et al. Characterization of prevalence and health consequences of uniparental disomy in four million individuals from the general population. Am J Hum Genet 2019; 105:921.
432 432. Matsubara K, Murakami N, Nagai T, et al. Maternal age effect on the development of Prader‐Willi syndrome resulting from upd(15)mat through meiosis I errors. J Hum Genet 2011; 56:566.
433 433. Hoffmann K, Heller R. Uniparental disomies 7 and 14. Best Pract Res Clin Endocrinol Metab 2011; 25:77.
434 434. Cho SY, Ki CS, Sohn YB, et al. The proportion of uniparental disomy is increased in Prader‐Willi syndrome due to an advanced maternal childbearing age in Korea. J Hum Genet 2013; 58:150.
435 435. Milunsky JM, Maher T, Lebo R, et al. Prenatal diagnosis for Schmid metaphyseal chondrodysplasia in twins. Fetal Diagn Ther 1998; 13:167.
436 436. Milunsky A, Ito M, Maher TA, et al. Prenatal molecular diagnosis of tuberous sclerosis complex. Am J Obstet Gynecol 2009; 200(3):321.
437 437. Piña‐Aguilar RE, Simpson SA, Alshatti A, et al. 27 years of prenatal diagnosis for Huntington disease in the United Kingdom. Genet Med 2019; 21:1639.
438 438. Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013; 14:248.
439 439. Milunsky A, Konialis C, Shim SH, et al. The prenatal diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) by mutation analysis. Prenat Diagn 2005; 25:1057.
440 440. Konialis C, Hagnefelt B, Kokkali G, et al. Pregnancy following preimplantation genetic diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Prenat Diagn 2007; 27:1079.
441 441. Middleton A, Hewison J, Mueller R. Prenatal diagnosis for inherited deafness: what is the potential demand? J Genet Couns 2001; 10:121.
442 442. Milunsky A, Alpert E, Kitzmiller JL, et al. Prenatal diagnosis of neural tube defects. VIII. The importance of serum α‐fetoprotein screening in diabetic pregnant women. Am J Obstet Gynecol 1982; 142:1030.
443 443. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal HbA1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981; 304:1331.
444 444. McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000; 9:14.
445 445. Penney GC, Mair G, Pearson DW, et al. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population‐based study. Br J Obstet Gynaecol 2003; 110:315.
446 446. Stormdal Bring H, Hultén Varli IA, Kublickas M, et al. Causes of stillbirth at different gestational ages in singleton pregnancies. Acta Obstet Gynecol Scand 2014; 93:86.
447 447. Kropff J, Selwood MP, McCarthy MI, et al. Prevalence of monogenic diabetes in young adults: a community‐based, cross‐sectional study in Oxfordshire, UK. Diabetologia 2011; 54:1261.
448 448. Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab 2013; 98:4055.
449 449. Kleinberger JW, Maloney KA, Pollin TI. The genetic architecture of diabetes in pregnancy: implications for clinical practice. Am J Perinatol 2016; 33:1319.
450 450. Stein SA, Maloney KL, Pollin TI. Genetic counseling for diabetes mellitus. Curr Genet Med Rep 2014; 2:56.
451 451. Dickens LT, Naylor RN. Clinical management of women with monogenic diabetes during pregnancy. Curr Diab Rep 2018; 188:12.
452 452. Shields BM, Hicks S, Shepherd MH, et al. Maturity‐onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010; 53(12):2504.
453 453. Colstrup M, Mathiesen ER, Damm P, et al. Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning foetal and neonatal complications? J Matern Fetal Neonatal Med 2013; 26:1682.
454 454. Schaefer‐Graf U, Napoli A, Nolan CJ. Diabetes in pregnancy: a new decade of challenges ahead. Diabetologia 2018; 61:1012.
455 455. Parimi M, Nitsch D. A systemic review and meta‐analysis of diabetes during pregnancy and congenital genitourinary abnormalities. Kidney Int Rep 2020; 5:678.
456 456. Mackin ST, Nelson SM, Kerssens JJ, et al. Diabetes and pregnancy: national trends over 15 year period. Diabetologia 2018; 61:1081.
457 457. Helle E, Priest JR. Maternal obesity and diabetes mellitus as risk factors for congenital heart disease in the offspring. J Am Heart Assoc 2020; 9:e011541.
458 458. Stogianni A, Lendahls L, Landin‐Olsson M, et al. Obstetric and perinatal outcomes in pregnancies complicated by diabetes, and control pregnancies, in Kronoberg, Sweden. BMC Pregnancy Childbirth 2019; 19:159.
459 459. Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 2019; 96:1.
460 460. Limaye MA, Buyon JP, Cuneo BF, et al. A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenat Diagn 2020; 40:1066.
461 461. Popescu MR, Dudu A, Jurcut C, et al. A broader perspective on Anti‐Ro antibodies and their fetal consequences – a case report and literature review. Diagnostics (Basel) 2020; 10:478.
462 462. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349:1526.
463 463. Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012; 64:2319.
464 464. Wainwright B, Bhan R, Trad C, et al. Autoimmune‐mediated congenital heart block. Best Pract Res Clin Obstet Gynaecol 2020; 64:41.
465 465. Panaitescu AM, Nicolaides K. Maternal autoimmune disorders and fetal defects. J Matern Fetal Neonatal Med 2018; 31:1798.
466 466. Brito‐Zerón P, Izmirly PM, Ramos‐Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 2015; 11:301.
467 467. Clowse ME, Eudy AM, Kiernan E, et al. The prevention, screening and treatment of congenital heart block from neonatal lupus:a survey of provider practices. Rheumatology 2018; 57(Suppl S5):v9.
468 468. Rein AJJT, Mevorach D, Perles Z, et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti‐SSA/Ro‐SSB/La antibodies a prospective, observational, fetal kinetocardiogram‐based study. Circulation 2009; 119:1867.
469 469. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 74:932.
470 470. Stanner C, Horndasch M, Vitanova K, et al. Neonates and infants requiring life‐long cardiac pacing: How reliable are epicardial leads through childhood? Int J Cardiol 2019; 297:43.
471 471. Izmirly PM, Costedoat‐Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti‐SSA/ro‐antibody – Associated cardiac manifestations of neonatal lupus. Circulation 2012; 126:76.
472 472. Hansahiranwadee W. Diagnosis and management of fetal autoimmune atrioventricular block. Int J Womens Health 2020; 12:633.
473 473. Pruetz JD, Miller JC, Loeb GE, et al. Prenatal diagnosis and management of congenital complete heart block. Birth Defects Res 2019; 111:380.
474 474. Thomas NS, Durkie M, Van Zyl B, et al. Parental and chromosomal origin of unbalanced de novo structural chromosome abnormalities in man. Hum Genet 2006; 119(4):444.
475 475.